New cancer drug combo tested in early trial
NCT ID NCT04989387
First seen Nov 01, 2025 · Last updated Apr 30, 2026 · Updated 23 times
Summary
This early-phase study tested a new drug called INCA00186, alone or with other immunotherapies, in 57 people with advanced solid tumors like head and neck or gastrointestinal cancers. The goal was to check safety, find the right dose, and see if the drug helps control the disease. The study was terminated early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cambridge University Hospitals Nhs Foundation Trust
Cambridge, CB2 0QQ, United Kingdom
-
Carolina Bio-Oncology Institute, Pllc
Huntersville, North Carolina, 28078, United States
-
Cliniques Universitaires Ucl Saint-Luc
Brussels, 01200, Belgium
-
Emory University
Atlanta, Georgia, 30322, United States
-
Erasmus Mc Cancer Institute
Rotterdam, 3015GD, Netherlands
-
Freeman Hospital Newcastle Upon Tyne Foundation Nhs Trust
Newcastle upon Tyne, NE7 7DN, United Kingdom
-
Fundacion Jimenez Diaz University Hospital
Madrid, 28040, Spain
-
Ghent University Hospital
Ghent, 09000, Belgium
-
Guys and St Thomas Nhs Foundation Trust
London, SE1 9RT, United Kingdom
-
Hackensack University Medical Center
Hackensack, New Jersey, 07601, United States
-
Hospital Clinico Universitario Virgen de La Victoria
Málaga, 29010, Spain
-
Hospital General Universitario Vall D Hebron
Barcelona, 08035, Spain
-
Hospital Universitario 12 de Octubre
Madrid, 28041, Spain
-
Hospital Universitario Quironsalud Madrid
Pozuelo de Alarcón, 28223, Spain
-
Imperial College Healthcare Nhs Trust - Hammersmith Hospital
London, W12 0HS, United Kingdom
-
Innsbruck University Hospital
Innsbruck, A-6020, Austria
-
Institut Catala Doncologia Ico - Hospital Duran I Reynals Location
Barcelona, 199203, Spain
-
Institut Jules Bordet
Brussels, B-1070, Belgium
-
Landeskrankenhaus Salzburg
Salzburg, 05020, Austria
-
Md Anderson Cancer Center
Houston, Texas, 77030, United States
-
Netherlands Cancer Institute Antoni Van Leeuwenhoek Ziekenhuis
Amsterdam, 1066 CX, Netherlands
-
Radboud University Nijmegen Medical Center
Nijmegen, 6525 GA, Netherlands
-
South Texas Accelerated Research Therapeutics
San Antonio, Texas, 78229, United States
-
The Angeles Clinic and Research Institute
Los Angeles, California, 90025, United States
-
The Christie Nhs Foundation Trust Uk
Manchester, M20 4BV, United Kingdom
-
The Royal Marsden Nhs Foundation Trust - Chelsea
Sutton, SM2 5PT, United Kingdom
-
Universitair Ziekenhuis (Uz) Leuven
Leuven, 03000, Belgium
-
Universitair Ziekenhuis Antwerpen (Uza)
Edegem, 02650, Belgium
-
University Medical Center Groningen
Groningen, 9713GZ, Netherlands
-
University Medical Center Utrecht
Utrecht, 3584 CX, Netherlands
-
University of Maryland-Greenebaum Cancer Center
Baltimore, Maryland, 21201, United States
-
Vanderbilt Medical Center
Nashville, Tennessee, 37232, United States
Conditions
Explore the condition pages connected to this study.